BJMO - volume 12, issue 7, november 2018
C. Vulsteke MD, PhD, M. del Pilar Ortega Arevalo , Ir C. Mouton MBA, K. Stam , R. Goethals , F. Ameye , C. Populaire , M. Peeters MD, PhD, P. Verdonck
Keeping up with the rising amount of clinical data, guidelines and approvals of new antineoplastic drugs is a major challenge for every oncologist. Artificial intelligence promises to address this and to revolutionise health care and cancer treatment. What is the current state of artificial intelligence for the oncologist, and is it ready for prime time? In this article, the current, available tools of artificial intelligence are highlighted, which try to take a privileged role in the daily practice of the oncologist.
(BELG J MED ONCOL 2018;12(7)330–333)
Read moreBJMO - volume 12, issue 5, september 2018
W. Lybaert MD, T. Vandamme MD, G. Boons , T. Rondou , M. Twickler , I. Dero MD, F. van Fraeyenhove MD, L. De Backer , D. Van Genechten , M. Peeters MD, PhD
March 7-9, 2018, Barcelona, Spain.
(BELG J MED ONCOL 2018:12(5):252–262)
Read moreBJMO - volume 12, issue 4, august 2018
M. Rasschaert MD, L. Triest MD, J. Van den Brande , K. Papadimitriou MD, H. Prenen MD, PhD, M. Peeters MD, PhD
The 2018 annual meeting of the American Society of Oncology (ASCO) was once more hosted in Chicago. Over 40,000 oncologists attended this years’ convention. This report will summarize the highlights from the gastro-intestinal cancer sessions at the meeting.
Read moreBJMO - volume 12, issue 3, may 2018
W. Lybaert MD, I. Dero MD, M. Peeters MD, PhD
With the background of the famous Golden Gate Bridge and Alcatraz, the annual Gastrointestinal Cancers Symposium was held from 18–20 January 2018 in the Moscone Congress Center in San Francisco, California. In this report, the most important headlines will be discussed, with comments on the clinical relevance of the different studies.
(BELG J MED ONCOL 2018:12(3):133–141)
Read moreBJMO - 12, issue 3, february 2018
T. Vandamme MD, I. Maurissen , W. Lybaert MD, M. Simoens , P. Abrams , A. Driessen MD, PhD, B. Op De Beeck , W. Demey MD, T. Rondou , M. Ulenaers , G. Vanhoutte , M. Peeters MD, PhD, Steering Commitee , NET-specialists
BJMO - 12, issue 3, february 2018
T. Vandamme MD, M. Beyens , G. Van Camp , G. Boons , L. Hofland , M. Peeters MD, PhD, K. Op de Beeck
BJMO - volume 11, issue 7, november 2017
L. Triest MD, K. Papadimitriou MD, M. Rasschaert MD, J. Van den Brande , M. Peeters MD, PhD
ESMO 2017 featured the presentation of several practice changing data in the field of gastrointestinal (GI) cancer. The first part of this report will summarize the key data presented in the field of gastric cancer, gastroesophageal junction (GEJ), biliary, gallbladder, biliary, pancreatic and hepatocellular cancer. In the second part, the focus is turned to colorectal cancer.
(BELG J ONCOL 2017;11(7):340–348)
Read more
Top
